Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

✍ Scribed by Edwin DeJesus; Jürgen K Rockstroh; Keith Henry; Jean-Michel Molina; Joseph Gathe; Srinivasan Ramanathan; Xuelian Wei; Kitty Yale; Javier Szwarcberg; Kirsten White; Andrew K Cheng; Brian P Kearney

• Book ID: 117310465
• Publisher: The Lancet
• Year: 2012
• Tongue: English
• Weight: 339 KB
• Volume: 379
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(12)60918-0